Related Experiment Videos
Synthesis and biological evaluation of1',2'-seconucleo-5'- phosphonates
S Racha1, C Vargeese, P Vemishetti
1Department of Medicinal Chemistry, University of Rhode Island, Kingston, Rhode Island 02881, USA.
Journal of Medicinal Chemistry
|March 1, 1996
Summary
Researchers synthesized novel nucleophosphonate analogues with common nucleobases. Antiviral screening against RNA, adeno, and HIV viruses revealed no significant activity for these compounds.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Virology
Background:
- Nucleophosphonates are structural analogues of nucleotides with potential therapeutic applications.
- Developing novel antiviral agents remains a critical area of research, particularly against RNA, adenovirus, and HIV.
Purpose of the Study:
- To synthesize and characterize a series of 1',2'-seconucleophosphonate analogues incorporating common nucleobases.
- To evaluate the in vitro antiviral activity of these novel compounds against selected viruses.
Main Methods:
- Synthesis of seconucleophosphonate analogues using chirons derived from diethyl (3S)-(benzyloxy)-(2R)-hydroxybutane-phosphonate and diethyl (3S),4-bis(benzyloxy)-(2R)-hydroxybutanephosphonate.
- Preparation of deblocked derivatives including monoesters, phosphonic acids, and a cyclic phosphonate.
- In vitro screening of selected derivatives against RNA, adeno, and HIV viruses.
Main Results:
- Successful synthesis of 1',2'-seconucleophosphonate analogues containing adenine, cytosine, thymine, and uracil.
- Deblocked derivatives, including monoesters, phosphonic acids, and a cyclic phosphonate, were prepared.
- None of the tested compounds exhibited in vitro antiviral activity against the screened viruses.
Conclusions:
- The synthesized 1',2'-seconucleophosphonate analogues, despite their novel structure, did not demonstrate antiviral efficacy in vitro.
- Further structural modifications or alternative biological targets may be necessary to develop active compounds in this class.